Innoviva (INVA) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -28.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.44% |
| Sep 30, 2025 | 9.38% |
| Jun 30, 2025 | 0.81% |
| Mar 31, 2025 | 31.23% |
| Sep 30, 2024 | 20.11% |
| Jun 30, 2024 | 14.50% |
| Mar 31, 2024 | 44.43% |
| Sep 30, 2023 | -44.22% |
| Jun 30, 2023 | -51.68% |
| Mar 31, 2023 | -73.85% |
| Sep 30, 2022 | -27.37% |
| Jun 30, 2022 | -6.61% |
| Mar 31, 2022 | 16.63% |
| Sep 30, 2021 | 256.01% |
| Jun 30, 2021 | 6.04% |
| Mar 31, 2021 | 14.48% |
| Dec 31, 2020 | 27.49% |
| Sep 30, 2020 | 29.89% |
| Jun 30, 2020 | 41.24% |
| Mar 31, 2020 | -4.16% |
| Dec 31, 2019 | 8.28% |
| Sep 30, 2019 | -4.51% |
| Jun 30, 2019 | 9.22% |
| Mar 31, 2019 | 53.57% |
| Dec 31, 2018 | 29.08% |
| Sep 30, 2018 | 38.23% |
| Jun 30, 2018 | 128.48% |
| Mar 31, 2018 | 79.80% |
| Dec 31, 2017 | 127.27% |
| Sep 30, 2017 | 118.04% |
| Jun 30, 2017 | 81.81% |
| Mar 31, 2017 | 282.91% |
| Dec 31, 2016 | 204.48% |
| Sep 30, 2016 | 650.98% |
| Jun 30, 2016 | 472.77% |
| Mar 31, 2016 | 546.98% |
| Dec 31, 2015 | 245.81% |
| Sep 30, 2015 | 112.61% |
| Jun 30, 2015 | 104.08% |
| Mar 31, 2015 | 96.90% |
| Dec 31, 2014 | 88.44% |
| Sep 30, 2014 | 49.28% |
| Jun 30, 2014 | -206.96% |
| Mar 31, 2014 | -61.43% |
| Dec 31, 2013 | -67.43% |
| Sep 30, 2013 | -47.69% |
| Jun 30, 2013 | 50.39% |
| Mar 31, 2013 | 23.71% |
| Dec 31, 2012 | 6.66% |
| Sep 30, 2012 | -45.82% |
| Jun 30, 2012 | -82.99% |
| Mar 31, 2012 | -55.58% |
| Dec 31, 2011 | -67.84% |
| Sep 30, 2011 | 0.24% |